T. King, Author at Compliance Insight - Page 4 of 6

March 21, 2023by T. King

The Benefits of Cell and Gene Therapy

March 13, 2023by T. King

FDA Clarifies Status of COVID-19 Guidance Documents Ahead of PHE Expiration

March 9, 2023by T. King

The Ten Core Principles of GMP Compliance

March 7, 2023by T. King

The Latest Update on the Umbrella EUA for Surgical Masks

March 2, 2023by T. King

Gene therapy is revolutionizing the way we treat genetic diseases

March 1, 2023by T. King

Clarify Regulatory Authority with FDORA Improvements

February 22, 2023by T. King

Monkeypox Emergency Authorization (EUA)

Document with title Audit

February 21, 2023by T. King

Are you prepared for when the FDA arrives…

Warning Letter

February 16, 2023by T. King

How to prepare for FDA Inspections

UDI_USA

February 7, 2023by T. King

Understanding UDI Requirements for Medical Devices

January 31, 2023by T. King

CBER Updates: What you need to know

January 16, 2023by T. King

What is an Unique Device Identifier (UDI)?

December 23, 2022by T. King

Happy holidays one and all!!

August 2, 2022by T. King

Goodness Gracious, Great Balls of Fire!

July 5, 2022by T. King

FDA Urges Drug Manufacturers to Implement Stronger Risk Management Plans

June 28, 2022by T. King

What is an UDI and why does it matter?

June 16, 2022by T. King

FDA authorizations for EUAs

Medical-Devices-scaled

June 7, 2022by T. King

The FDA Is Adopting ISO 13485: What This Means for Medical Devices

Baby milk formula on kitchen background

June 2, 2022by T. King

FDA Announces Increased Flexibilities Regarding Importation of Infant Formula

May 27, 2022by T. King

Happy Memorial Day

April 7, 2022by T. King

Compliance Insight Named Top 10